Trial intelligence / Profile preview

GLP-1 for bridging of hyperglycaemia during cardiac surgery

2017-000043-40Phase 4Completed

Sponsor
Academic Medical Center
Start
Jan 2017
Modality
Peptides
Countries
1
01

Overview

Phase 4, randomised trial of liraglutide in hyperglycemia (2 arms), sponsored by Academic Medical Center. Primary endpoint: Proportion of patients needing insulin therapy perioperatively. Started Jan 2017; status: completed.

02

Drugs

03

Conditions

hyperglycemia

Beyond the preview

Go deeper on 2017-000043-40.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2017-000043-40.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call